BioAge Labs, Inc. — All Filings
130 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13G
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | — | 0001415889-25-016281 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0000950170-25-083746 | Jun 9, 2025 | Jun 5, 2025 |
| 8-K | 8-K | 0000950170-25-081409 | Jun 4, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-064552 | May 6, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-064547 | May 6, 2025 | — |
| ARS | ARS | 0000950170-25-055400 | Apr 17, 2025 | Dec 31, 2024 |
| DEFA14A | DEFA14A | 0000950170-25-055384 | Apr 17, 2025 | — |
| DEF 14A | DEF 14A | 0000950170-25-055371 | Apr 17, 2025 | Jun 5, 2025 |
| S-8 | S-8 | 0000950170-25-042779 | Mar 20, 2025 | — |
| 10-K | 10-K | 0000950170-25-042759 | Mar 20, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-042747 | Mar 20, 2025 | — |
| 4/A | — | 0001415889-25-007506 | Mar 10, 2025 | Apr 17, 2024 |
| 4 | — | 0001415889-25-007505 | Mar 10, 2025 | Sep 27, 2024 |
| 4/A | — | 0001415889-25-005496 | Feb 25, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004867 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004864 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004859 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004857 | Feb 20, 2025 | Feb 18, 2025 |
| 4 | — | 0001415889-25-004854 | Feb 20, 2025 | Feb 18, 2025 |
| SCHEDULE 13G/A | — | 0001415889-25-004265 | Feb 14, 2025 | — |
| SCHEDULE 13G | — | 0001172661-25-001097 | Feb 14, 2025 | — |
| 4 | — | 0001415889-24-029962 | Dec 20, 2024 | Dec 18, 2024 |
| SC 13G | SC 13G | 0001193125-24-258589 | Nov 14, 2024 | — |
| SC 13G | SC 13G | 0001104659-24-116796 | Nov 12, 2024 | — |
| 8-K | 8-K | 0000950170-24-123437 | Nov 7, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-123445 | Nov 7, 2024 | Sep 30, 2024 |
| SC 13G | SC 13G | 0001104659-24-106678 | Oct 7, 2024 | — |
| SC 13D | SC 13D | 0001104659-24-106374 | Oct 4, 2024 | — |
| 4 | — | 0001415889-24-024688 | Oct 3, 2024 | Oct 1, 2024 |
| 4 | — | 0000929638-24-003363 | Oct 1, 2024 | Sep 27, 2024 |
| SC 13D | SC 13D | 0001104659-24-104494 | Sep 30, 2024 | — |
| 4 | — | 0001415889-24-024040 | Sep 27, 2024 | Apr 17, 2024 |
| 4 | — | 0001415889-24-024047 | Sep 27, 2024 | — |
| 4 | — | 0001415889-24-024046 | Sep 27, 2024 | Sep 25, 2024 |
| 4 | — | 0001415889-24-024045 | Sep 27, 2024 | Apr 17, 2024 |
| 4 | — | 0001415889-24-024044 | Sep 27, 2024 | Sep 25, 2024 |
| 4 | — | 0001415889-24-024043 | Sep 27, 2024 | Apr 17, 2024 |
| 4 | — | 0001415889-24-024042 | Sep 27, 2024 | Mar 26, 2024 |
| 4 | — | 0001415889-24-024041 | Sep 27, 2024 | Aug 19, 2024 |
| 8-K | 8-K | 0001193125-24-227949 | Sep 27, 2024 | Sep 25, 2024 |
| S-8 | S-8 | 0001193125-24-227045 | Sep 26, 2024 | — |
| 424B4 | 424B4 | 0001193125-24-226927 | Sep 26, 2024 | — |
| 3 | — | 0001415889-24-023956 | Sep 25, 2024 | — |
| SEC STAFF LETTER | — | 9999999997-24-003958 | Sep 25, 2024 | — |
| EFFECT | — | 9999999995-24-002965 | Sep 25, 2024 | — |
| 3 | — | 0000929638-24-003233 | Sep 25, 2024 | — |
| S-1MEF | S-1MEF | 0001193125-24-226258 | Sep 25, 2024 | — |
| 3 | — | 0001415889-24-023966 | Sep 25, 2024 | — |
| 3 | — | 0001415889-24-023965 | Sep 25, 2024 | — |
| 3 | — | 0001415889-24-023964 | Sep 25, 2024 | — |